布美他尼在治疗肝病所致腹水方面的应用。
Use of bumetanide in the treatment of ascites due to liver disease.
作者信息
Moult P J, Lunzer M R, Trash D B, Sherlock S
出版信息
Gut. 1974 Dec;15(12):988-92. doi: 10.1136/gut.15.12.988.
Abstract
Bumetanide is an effective diuretic for the treatment of ascites. Fifteen out of 17 patients with chronic liver disease responded satisfactorily and the incidence of hepatic encephalopathy and electrolyte disturbances was similar to that previously observed with frusemide. Colicky abdominal pain was reported in three patients but no other adverse effects were noted. An unexpected response was obtained in two patients who had diuresis without natriuresis.
摘要
布美他尼是治疗腹水的一种有效利尿剂。17例慢性肝病患者中有15例反应良好，肝性脑病和电解质紊乱的发生率与先前使用速尿时观察到的相似。3例患者报告有绞痛性腹痛，但未观察到其他不良反应。有2例患者出现了不排钠的利尿反应，这是一种意外的反应。
相似文献
1
Use of bumetanide in the treatment of ascites due to liver disease.布美他尼在治疗肝病所致腹水方面的应用。
Gut. 1974 Dec;15(12):988-92. doi: 10.1136/gut.15.12.988.
2
Bumetanide in the treatment of hepatic ascites. A short and long-term study.布美他尼治疗肝腹水。一项短期和长期研究。
Acta Med Scand. 1974 May;195(5):411-4. doi: 10.1111/j.0954-6820.1974.tb08161.x.
3
Bumetanide, a new diuretic.布美他尼，一种新型利尿剂。
Int Urol Nephrol. 1974;6(1):35-42. doi: 10.1007/BF02086910.
4
5
Bumetanide, a new potent diuretic. A clinical evaluation in congestive heart failure.布美他尼，一种新型强效利尿剂。充血性心力衰竭的临床评估。
Acta Med Scand. 1973 Jan-Feb;193(1-2):119-31.
6
Complications of diuresis in the alcoholic patient with ascites: a controlled trial.酒精性腹水患者利尿的并发症：一项对照试验。
Gastroenterology. 1977 Sep;73(3):534-8.
7
8
Clinical trial of a new diuretic, bumetanide, in seriously ill patients.新型利尿剂布美他尼用于重症患者的临床试验。
Ann Clin Res. 1974 Oct;6(5):272-8.
9
10
Evaluation in man of bumetanide, a new diuretic agent.新型利尿剂布美他尼在人体中的评估。
Eur J Clin Pharmacol. 1973 Dec;6(4):224-7. doi: 10.1007/BF00644736.
引用本文的文献
1
Off-Label Use of Bumetanide for Brain Disorders: An Overview.布美他尼在脑部疾病中的超说明书用药概述
Front Neurosci. 2019 Apr 24;13:310. doi: 10.3389/fnins.2019.00310. eCollection 2019.
2
Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level.新型袢利尿剂吡咯他尼在肝硬化腹水患者中的应用：利尿反应与血浆醛固酮水平的关系
Gut. 1980 Oct;21(10):855-9. doi: 10.1136/gut.21.10.855.
3
Pharmacotherapy of ascites associated with cirrhosis.肝硬化相关腹水的药物治疗。
Drugs. 1992 Mar;43(3):316-32. doi: 10.2165/00003495-199243030-00003.
4
Diuretic action of bumetanide in advanced chronic renal insufficiency.布美他尼在晚期慢性肾功能不全中的利尿作用。
Eur J Clin Pharmacol. 1976 Feb 6;9(4):265-75. doi: 10.1007/BF00561659.
本文引用的文献
1
BODY AND SERUM POTASSIUM IN LIVER DISEASE. I. RELATIONSHIP TO HEPATIC FUNCTION AND ASSOCIATED FACTORS.肝病患者体内及血清中的钾。I. 与肝功能及相关因素的关系
Gastroenterology. 1965 Feb;48:198-207.
2
Clinical disorders of urine concentration and dilution.尿液浓缩与稀释的临床病症。
Arch Intern Med. 1973 Jun;131(6):810-25.
3
Bumetanide, a new potent diuretic. A clinical evaluation in congestive heart failure.布美他尼，一种新型强效利尿剂。充血性心力衰竭的临床评估。
Acta Med Scand. 1973 Jan-Feb;193(1-2):119-31.
4
Bumetanide: potent new "loop" diuretic.布美他尼：强效新型“袢”利尿剂。
Br Med J. 1972 Jan 22;1(5794):211-3. doi: 10.1136/bmj.1.5794.211.
5
Complications of diuretic therapy in hepatic cirrhosis.
Lancet. 1966 May 14;1(7446):1049-52. doi: 10.1016/s0140-6736(66)91005-1.
Zotero 插件